(Q41918713)

14 October 2017

title

Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma (English)

1 reference

14 October 2017

1 reference

14 October 2017

1 reference

14 October 2017

Erwin Bottinger

1 reference

14 October 2017

Samuel Waxman

1 reference

14 October 2017

Vincenzo Mazzaferro

1 reference

14 October 2017

Myron Schwartz

1 reference

14 October 2017

Swan Thung

1 reference

14 October 2017

Sasan Roayaie

1 reference

14 October 2017

Elisa Wurmbach

1 reference

14 October 2017

Isabel Fiel

1 reference

14 October 2017

Ying-bei Chen

1 reference

14 October 2017

Greg Khitrov

series ordinal

1 reference

14 October 2017

Weijia Zhang

series ordinal

1 reference

14 October 2017

Scott Friedman

series ordinal

1 reference

14 October 2017

language of work or name

English

0 references

publication date

1 April 2007

1 reference

14 October 2017

1 reference

14 October 2017

1 reference

14 October 2017

1 reference

14 October 2017

page(s)

938-947

1 reference

Molecular profiling of hepatocellular carcinomas (HCC) using a large-scale real-time RT-PCR approach: determination of a molecular diagnostic index

14 October 2017

cites work

1 reference

Global cancer statistics, 2002

21 January 2018

1 reference

7 January 2021

Rising incidence of hepatocellular carcinoma in the United States

1 reference

7 January 2021

Hepatocellular carcinoma

1 reference

7 January 2021

Focus on hepatocellular carcinoma.

1 reference

7 January 2021

Molecular pathogenesis of human hepatocellular carcinoma

1 reference

7 January 2021

Hepatocellular carcinoma pathogenesis: from genes to environment

1 reference

7 January 2021

Molecular prognostication of liver cancer: end of the beginning

1 reference

7 January 2021

Identification, using cDNA macroarray analysis, of distinct gene expression profiles associated with pathological and virological features of hepatocellular carcinoma

1 reference

7 January 2021

Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning

1 reference

7 January 2021

Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling.

1 reference

7 January 2021

Molecular-based prediction of early recurrence in hepatocellular carcinoma

1 reference

7 January 2021

Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection.

1 reference

7 January 2021

Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling.

1 reference

7 January 2021

A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells

1 reference

7 January 2021

Newer markers for hepatocellular carcinoma

1 reference

7 January 2021

Expression profiling in multistage hepatocarcinogenesis: identification of HSP70 as a molecular marker of early hepatocellular carcinoma.

1 reference

7 January 2021

Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma

1 reference

7 January 2021

A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.

1 reference

7 January 2021

Minimum information about a microarray experiment (MIAME)-toward standards for microarray data

1 reference

7 January 2021

Focused microarray analysis

1 reference

7 January 2021

Antifibrotic agents for liver disease

1 reference

7 January 2021

Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection.

1 reference

7 January 2021

An integrated data analysis approach to characterize genes highly expressed in hepatocellular carcinoma

1 reference

7 January 2021

Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues

1 reference

7 January 2021

Integrative genomics based identification of potential human hepatocarcinogenesis-associated cell cycle regulators: RHAMM as an example

1 reference

7 January 2021

Management of hepatocellular carcinoma

1 reference

7 January 2021

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

1 reference

7 January 2021

Amplifications of DNA primase 1 (PRIM1) in human osteosarcoma

1 reference

7 January 2021

The microcephaly ASPM gene is expressed in proliferating tissues and encodes for a mitotic spindle protein

1 reference

7 January 2021

Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for H-ras transformation

1 reference

7 January 2021

Hepatocellular carcinoma: molecular pathways and new therapeutic targets.

1 reference

7 January 2021

Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis

1 reference

7 January 2021

Oncogenic role of the frizzled-7/beta-catenin pathway in hepatocellular carcinoma

1 reference

7 January 2021

Ubiquitous activation of Ras and Jak/Stat pathways in human HCC.

1 reference

7 January 2021

JAGGED1 expression is associated with prostate cancer metastasis and recurrence

1 reference

7 January 2021

Hepatitis C virus expression suppresses interferon signaling by degrading STAT1

1 reference

7 January 2021

Sprouty 2, an inhibitor of mitogen-activated protein kinase signaling, is down-regulated in hepatocellular carcinoma.

1 reference

7 January 2021

Decorin protein core inhibits in vivo cancer growth and metabolism by hindering epidermal growth factor receptor function and triggering apoptosis via caspase-3 activation

1 reference

7 January 2021

Overexpression of human Dickkopf-1, an antagonist of wingless/WNT signaling, in human hepatoblastomas and Wilms' tumors.

1 reference

7 January 2021

Dysregulation of the Hedgehog pathway in human hepatocarcinogenesis

1 reference

7 January 2021

Multiple tumor suppressor pathways negatively regulate telomerase

1 reference

7 January 2021

Partial downregulation of MAD1 causes spindle checkpoint inactivation and aneuploidy, but does not confer resistance towards taxol

1 reference

7 January 2021

GADD45-alpha expression in cirrhosis and hepatocellular carcinoma: relationship with DNA repair and proliferation.

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.21622

1 reference

14 October 2017

1 reference